Literature DB >> 9327721

Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.

P F Stahel1, K Frei, A Fontana, H P Eugster, B H Ault, S R Barnum.   

Abstract

Complement has been shown to contribute to intrathecal inflammation in bacterial meningitis. However, the cellular source of complement in the infected central nervous system has not been determined. In this study, we analyzed protein and mRNA expression of two alternative pathway complement activation proteins, C3 and factor B, in the brains of mice with Listeria monocytogenes meningitis. Complement protein levels were found elevated in the cerebrospinal fluid of infected mice, compared with mock-infected animals. In the course of the disease, enhanced C3 and factor B mRNA expression was detected on pyramidal neurons and Purkinje cells within 6 hours, peaking at 12 hours and then gradually decreasing by 72 hours after infection. In addition, leukocytes infiltrating the subarachnoid space, within 12 to 24 hours, expressed mRNA for C3 and factor B. The cellular infiltration increased dramatically up to 72 hours. Intraperitoneal injection of tumor necrosis factor (TNF)-alpha up-regulated C3 and factor B mRNA expression on neurons in normal mice, suggesting that TNF-alpha may represent one cytokine regulating complement expression in this model of bacterial meningitis. However, additional mediators may be involved in regulation of intrathecal complement expression, as infected mice deficient of TNF/lymphotoxin-alpha genes did not demonstrate attenuated complement expression in the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9327721      PMCID: PMC1858032     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  36 in total

Review 1.  Bacterial meningitis: pathogenesis, pathophysiology, and progress.

Authors:  V Quagliarello; W M Scheld
Journal:  N Engl J Med       Date:  1992-09-17       Impact factor: 91.245

2.  Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes.

Authors:  P M Faustmann; D Krause; R Dux; R Dermietzel
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 3.  Adjunctive therapy for bacterial meningitis: rationale for use, current status, and prospects for the future.

Authors:  G C Townsend; W M Scheld
Journal:  Clin Infect Dis       Date:  1993-11       Impact factor: 9.079

4.  Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro.

Authors:  I Rozovsky; T E Morgan; D A Willoughby; M M Dugichi-Djordjevich; G M Pasinetti; S A Johnson; C E Finch
Journal:  Neuroscience       Date:  1994-10       Impact factor: 3.590

5.  Cellular specificity of murine renal C3 expression in two models of inflammation.

Authors:  B H Ault; H R Colten
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

6.  Mechanisms of brain injury in bacterial meningitis: workshop summary.

Authors:  H W Pfister; A Fontana; M G Täuber; A Tomasz; W M Scheld
Journal:  Clin Infect Dis       Date:  1994-09       Impact factor: 9.079

7.  Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

Authors:  E G Gutierrez; W A Banks; A J Kastin
Journal:  J Neuroimmunol       Date:  1993-09       Impact factor: 3.478

8.  Improved accuracy in diagnostic immunohistochemistry, lectin histochemistry and in situ hybridization using a gold-labeled horseradish peroxidase antibody and silver intensification.

Authors:  J Roth; P Saremaslani; M J Warhol; P U Heitz
Journal:  Lab Invest       Date:  1992-08       Impact factor: 5.662

9.  Cerebrovascular permeability changes during experimental meningitis in the rat.

Authors:  K M Boje
Journal:  J Pharmacol Exp Ther       Date:  1995-09       Impact factor: 4.030

10.  Listeria meningitis: identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin 10.

Authors:  K Frei; D Nadal; H W Pfister; A Fontana
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

View more
  5 in total

Review 1.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

Review 2.  Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease.

Authors:  S R Barnum
Journal:  Mol Med       Date:  1999-09       Impact factor: 6.354

Review 3.  Chemotactic factors in cerebrospinal fluid during bacterial meningitis.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; John J Roord; A Marceline van Furth
Journal:  Infect Immun       Date:  2006-03       Impact factor: 3.441

Review 4.  The complement system in central nervous system diseases.

Authors:  H Rus; F Niculescu
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  Expression of innate immune complement regulators on brain epithelial cells during human bacterial meningitis.

Authors:  Cecile Canova; Jim W Neal; Philippe Gasque
Journal:  J Neuroinflammation       Date:  2006-09-02       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.